Board Meeting Outcome
Deep Health AI India Limited (DDIL) has announced that its Board of Directors deferred an agenda item during the meeting held on May 27, 2026. The deferred item pertains to the consideration and approval of the Audited Standalone and Consolidated Financial Results for the Financial Year ended March 31, 2026, along with the Draft Statutory Auditor's Report thereon.
The company cited Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as the regulatory basis for this agenda item. The matter has been rescheduled and will now be taken up for consideration on Friday, May 29, 2026.
Revised Filing Details
This announcement serves as a replacement for the earlier filing made on May 27, 2026. The revised outcome includes corrections to typographical errors that were present in the prior submission. Investors and stakeholders are requested to consider this revised filing as the official version for reference purposes.
The company had initially informed the exchange about the Board meeting through its intimation dated May 22, 2026. The deferral of financial results approval is a routine procedural matter under SEBI listing regulations.
Background and Context
Under SEBI LODR Regulations, listed companies are required to disclose their audited financial results within stipulated timelines at the end of each financial year. Regulation 33 specifically governs the disclosure of financial results and the submission of audit reports. Companies may defer such considerations when additional time is needed for review or to address procedural requirements.
The deferral from May 27 to May 29 represents a short two-day shift in the scheduled approval timeline. Market participants typically monitor such announcements to track the financial disclosure schedule of listed entities.
Next Steps
Stakeholders are advised to await the official financial results filing, now scheduled for May 29, 2026. Any further updates regarding the Audited Standalone and Consolidated Financial Results for FY ended March 31, 2026 will be communicated through official exchange filings.
This article is based solely on the corporate announcement filed by Deep Health AI India Limited with BSE. The information provided here is for informational purposes only and should not be construed as financial or investment advice. Investors are advised to exercise their own discretion and consult qualified professionals before making any investment decisions.